Effect of native lung disease on post-transplant best lung function

Area of Science:

• Pulmonary Medicine
• Transplant Surgery
• Critical Care

Background:

• Lung transplantation is a vital treatment for end-stage lung diseases.
• Pre-existing lung conditions can affect post-transplant outcomes.
• Understanding the impact of native lung disease type is crucial for patient management.

Purpose of the Study:

• To evaluate how native obstructive versus restrictive lung diseases affect post-transplant pulmonary function.
• To compare best Forced Expiratory Volume in 1 second (FEV1) and Forced Vital Capacity (FVC) between these groups.

Main Methods:

• Retrospective cohort study of 148 adult bilateral lung transplant recipients (2009-2021).
• Patients classified as obstructive or restrictive based on pre-transplant diagnosis.
• Analysis of post-transplant best FEV1 and FVC Z-scores using t-tests, Kaplan-Meier, and regression models.

Main Results:

• Restrictive lung disease group showed lower post-transplant best FEV1 (Z-score: 0.70) and FVC (Z-score: 0.61) compared to obstructive.
• The restrictive group achieved peak FVC earlier (median 142 days vs. 297 days).
• Native lung disease type was not a significant independent predictor of post-transplant lung function after adjustment.

Conclusions:

• Native restrictive lung disease is associated with reduced post-transplant lung function.
• However, this association is not independent when other factors are considered.
• Lung disease type alone does not predict long-term lung function post-transplant.